Syncope, a transient loss of consciousness due to inadequate cerebral blood flow, poses a significant clinical challenge. Despite its high prevalence, the etiological determination and management of syncope remain complex. This article aims to provide a comprehensive approach to syncope in clinical practice.
Syncope primarily results from a sudden drop in cerebral perfusion. It can be classified into reflex, orthostatic hypotension, and cardiac syncope. Reflex syncope, the most common type, includes vasovagal, situational, and carotid sinus syncope. Understanding the underlying pathophysiology aids in accurate diagnosis and effective management.
An initial evaluation of syncope should include a detailed history and physical examination. Specific attention should be given to preceding symptoms, triggers, and recovery period. ECG and orthostatic blood pressure measurements are essential first-line investigations. Further diagnostic tests should be guided by clinical suspicion.
Management of syncope should be tailored according to the underlying cause. Non-pharmacological measures such as education, lifestyle modifications, and physical counterpressure maneuvers form the cornerstone of therapy for reflex syncope. Pharmacological treatment may be considered in recurrent cases. Cardiac syncope requires a more aggressive approach, including pacemaker implantation or cardiac surgery, depending on the underlying pathology.
Prognosis of syncope largely depends on the etiology. While reflex syncope has a benign course, cardiac syncope is associated with increased morbidity and mortality. Regular follow-up is essential to assess the response to treatment and to monitor for potential complications.
Syncope is a multifaceted clinical entity that necessitates a comprehensive approach for effective management. A thorough understanding of its pathophysiology, coupled with a systematic diagnostic approach and tailored management strategies, can significantly improve patient outcomes. As clinicians, we must remain vigilant to the complexities of syncope to provide optimal patient care.
1.
Year in Review: Non-Small Cell Lung Cancer
2.
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
3.
The need for more Latinx participants in Alzheimer's trials is urgent.
4.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
5.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
1.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
2.
The Danger of Methemoglobinemia and How to Prevent It
3.
Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Thromboprophylaxis In Medical Settings
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation